Today: 1 May 2026
Browse Category

NASDAQ:CRWD 28 September 2025 - 29 November 2025

CrowdStrike (CRWD) Stock Rises to $509 as Flex, AI and SIEM Momentum Build Ahead of Q3 Earnings – November 28, 2025

CrowdStrike (CRWD) Stock Rises to $509 as Flex, AI and SIEM Momentum Build Ahead of Q3 Earnings – November 28, 2025

CrowdStrike shares closed at $509.16 on November 28, up 1.5% in light post-holiday trading, outperforming major indexes. The stock remains about 10% below its November high despite a year-to-date gain of over 50%. Evercore ISI reiterated its “In Line” rating with a $430 target, citing improving Falcon Flex momentum. Recent analyst targets have climbed as CrowdStrike’s AI and SIEM offerings draw attention ahead of earnings.
29 November 2025
·····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 28.11.2025

NVIDIA shares fell 14.5% in November, despite a 28% year-to-date gain. A discounted cash flow model values the stock at $165.42 per share, about 7% below its current price. CrowdStrike surged 47.2% over the past year but trades 12.6% above its DCF-based fair value. SMX stock doubled intraday on November 29, with volume nearly nine times average, as speculative trading spiked.
28 November 2025
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.11.2025

Ulta Beauty fell 1.9% to $497.72, underperforming the S&P 500's 0.38% gain, as investors await Q2 earnings. Nutanix dipped 0.18% to $72.07 but remains up 10.3% over the month. CrowdStrike rose 1.85% ahead of earnings, with a Forward P/E of 75.02. Okta dropped 1.14% to $80.11, down 9.41% for the month.
19 November 2025
···
CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

CrowdStrike Stock: Rosenblatt Hikes Price Target to $630 as AI Security Alliances and Google Recognition Ignite Wall Street

Rosenblatt raised its price target for CrowdStrike to $630 on November 18, 2025, citing strong AI security partnerships, including new alliances with Google Cloud. Capital One and Berenberg also lifted their targets to $599 and $600, respectively. Recent analyst upgrades have pushed CrowdStrike’s one-year target range to $540–$630.
18 November 2025
··
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CRWD Stock Today (Nov 15, 2025): CrowdStrike’s AI Push, New Partnerships and What to Expect Into December Earnings

CrowdStrike shares remain near record highs after announcing new AI security products, partnerships with F5, Google, and CoreWeave, and a major EY contract in November. The stock hit an all-time closing high of $557.53 on Nov. 10, 2025, and now trades in the $530s. Analysts remain positive ahead of CrowdStrike’s earnings call set for Dec. 2.
15 November 2025
····
CrowdStrike (CRWD) news today — Nov 12, 2025: F5 alliance embeds Falcon in BIG‑IP, RBC lifts price target to $621, and CEO Kurtz linked to Mercedes F1 stake

CrowdStrike (CRWD) news today — Nov 12, 2025: F5 alliance embeds Falcon in BIG‑IP, RBC lifts price target to $621, and CEO Kurtz linked to Mercedes F1 stake

CrowdStrike and F5 announced integration of Falcon security into BIG-IP appliances, free for eligible customers through October 2026. RBC raised CrowdStrike’s price target to $621. Reuters reports CEO George Kurtz is in talks to buy about 5% of Mercedes F1. CRWD shares traded down 0.7% at $552.71 mid-session.
12 November 2025
·
5 AI Stocks Set to Soar: Best Buys for October 2025’s Tech Boom

AI Stocks Fall on November 6, 2025: Nvidia, AMD, Palantir Lead Slide as Valuation Jitters Return

U.S. stocks with heavy AI exposure fell sharply Thursday, with AMD down 8%, Salesforce off 6.6%, and Nvidia losing 2.6% by late morning. Microsoft, Amazon, and other megacaps also slipped as renewed tech selling and macro uncertainty weighed on markets. Datadog jumped 22% after strong results, bucking the broader decline. Tariff questions and mixed economic data added to pressure on high-growth tech shares.
6 November 2025
·····················
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike closed at $521.98 on Oct. 23, just below its all-time high, after rising nearly 40% year-to-date. Q2 FY2026 revenue reached $1.17 billion, up 21% year-over-year, with EPS of $0.93, both beating estimates. The company acquired Onum for $290 million and launched new AI security features. About 28 of 48 analysts rate CRWD a Buy, with average price targets near $496.
24 October 2025
··
AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

The Nasdaq hit about 22,680 and the S&P 500 hovered near 6,664 as investors poured into AI-driven growth stocks. Nvidia surged nearly 60% year-over-year, while AMD almost doubled in 2025 after major AI chip deals. CrowdStrike traded near record highs, up 56% annually. Analysts remain bullish, but some warn valuations are stretched.
20 October 2025
·········
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Climbs on AI Cybersecurity Momentum and Analyst Upgrades – What’s Next for CRWD?

CrowdStrike shares closed at $484.65 Friday, up 0.5% for the day but slightly down for the week, near record highs. The company was named a “Visionary” in Gartner’s 2025 Magic Quadrant for SIEM and expanded its AI security partnership with Wipro. Last quarter, revenue rose 21% to $1.17 billion with EPS of $0.93, beating estimates. Wall Street remains bullish, with most analysts rating the stock a Buy.
19 October 2025
·
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike shares trade near $500 after a 65% year-on-year surge, giving the cybersecurity firm a $125 billion market cap and a valuation of about 135 times forward earnings. The company agreed in August to buy Onum for $290 million and unveiled new AI-powered security features in September. Revenue rose 21% last quarter to $740 million with EPS of $0.93. Wall Street remains broadly bullish, with most analysts rating the stock a Buy.
8 October 2025
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Nasdaq Surges Amid AI Frenzy and Fed Optimism – EA Skyrockets on $50B Buyout Buzz

The Nasdaq Composite closed at 22,484.07 on Sept. 26, up 0.44% for the day but down about 0.7% for the week. Electronic Arts surged 15% on reports of a $50 billion go-private deal, while CarMax plunged 20% after missing Q2 estimates. Navan and Lendbuzz filed for Nasdaq IPOs amid renewed tech IPO activity. Investors await major tech earnings in early October, focusing on AI demand.
28 September 2025
·············
1 … 4 5 6

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:12 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop